208 related articles for article (PubMed ID: 14505382)
1. Designed helical peptides inhibit an intramembrane protease.
Das C; Berezovska O; Diehl TS; Genet C; Buldyrev I; Tsai JY; Hyman BT; Wolfe MS
J Am Chem Soc; 2003 Oct; 125(39):11794-5. PubMed ID: 14505382
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of gamma-secretase activity by helical beta-peptide foldamers.
Imamura Y; Watanabe N; Umezawa N; Iwatsubo T; Kato N; Tomita T; Higuchi T
J Am Chem Soc; 2009 Jun; 131(21):7353-9. PubMed ID: 19432477
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a Subnanomolar helical D-tridecapeptide inhibitor of gamma-secretase.
Bihel F; Das C; Bowman MJ; Wolfe MS
J Med Chem; 2004 Jul; 47(16):3931-3. PubMed ID: 15267231
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of gamma-secretase cleavage activation: is gamma-secretase regulated through autoinhibition involving the presenilin-1 exon 9 loop?
Knappenberger KS; Tian G; Ye X; Sobotka-Briner C; Ghanekar SV; Greenberg BD; Scott CW
Biochemistry; 2004 May; 43(20):6208-18. PubMed ID: 15147205
[TBL] [Abstract][Full Text] [Related]
5. A substrate-based difluoro ketone selectively inhibits Alzheimer's gamma-secretase activity.
Wolfe MS; Citron M; Diehl TS; Xia W; Donkor IO; Selkoe DJ
J Med Chem; 1998 Jan; 41(1):6-9. PubMed ID: 9438016
[No Abstract] [Full Text] [Related]
6. Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease.
Pollack SJ; Lewis H
Curr Opin Investig Drugs; 2005 Jan; 6(1):35-47. PubMed ID: 15675602
[TBL] [Abstract][Full Text] [Related]
7. Conserved residues within the putative active site of gamma-secretase differentially influence enzyme activity and inhibitor binding.
Wrigley JD; Nunn EJ; Nyabi O; Clarke EE; Hunt P; Nadin A; De Strooper B; Shearman MS; Beher D
J Neurochem; 2004 Sep; 90(6):1312-20. PubMed ID: 15341515
[TBL] [Abstract][Full Text] [Related]
8. gamma-Secretase as a target for drug intervention in Alzheimer's disease.
Harrison T; Churcher I; Beher D
Curr Opin Drug Discov Devel; 2004 Sep; 7(5):709-19. PubMed ID: 15503873
[TBL] [Abstract][Full Text] [Related]
9. Efficient inhibition of the Alzheimer's disease beta-secretase by membrane targeting.
Rajendran L; Schneider A; Schlechtingen G; Weidlich S; Ries J; Braxmeier T; Schwille P; Schulz JB; Schroeder C; Simons M; Jennings G; Knölker HJ; Simons K
Science; 2008 Apr; 320(5875):520-3. PubMed ID: 18436784
[TBL] [Abstract][Full Text] [Related]
10. In vitro gamma-secretase cleavage of the Alzheimer's amyloid precursor protein correlates to a subset of presenilin complexes and is inhibited by zinc.
Hoke DE; Tan JL; Ilaya NT; Culvenor JG; Smith SJ; White AR; Masters CL; Evin GM
FEBS J; 2005 Nov; 272(21):5544-57. PubMed ID: 16262694
[TBL] [Abstract][Full Text] [Related]
11. Molecular docking and 3D-QSAR studies on the binding mechanism of statine-based peptidomimetics with beta-secretase.
Zuo Z; Luo X; Zhu W; Shen J; Shen X; Jiang H; Chen K
Bioorg Med Chem; 2005 Mar; 13(6):2121-31. PubMed ID: 15727865
[TBL] [Abstract][Full Text] [Related]
12. The gamma-secretase complex: membrane-embedded proteolytic ensemble.
Wolfe MS
Biochemistry; 2006 Jul; 45(26):7931-9. PubMed ID: 16800619
[TBL] [Abstract][Full Text] [Related]
13. Gamma-secretase: a catalyst of Alzheimer disease and signal transduction.
Li YM
Mol Interv; 2001 Oct; 1(4):198-207. PubMed ID: 14993342
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitor.
Barten DM; Guss VL; Corsa JA; Loo A; Hansel SB; Zheng M; Munoz B; Srinivasan K; Wang B; Robertson BJ; Polson CT; Wang J; Roberts SB; Hendrick JP; Anderson JJ; Loy JK; Denton R; Verdoorn TA; Smith DW; Felsenstein KM
J Pharmacol Exp Ther; 2005 Feb; 312(2):635-43. PubMed ID: 15452193
[TBL] [Abstract][Full Text] [Related]
15. [Pathogenesis of Alzheimer's disease: implications from amyloid research front].
Iwatsubo T
Rinsho Shinkeigaku; 2004 Nov; 44(11):768-70. PubMed ID: 15651286
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of highly active Alzheimer's beta-secretase (BACE1) inhibitors, KMI-420 and KMI-429, with enhanced chemical stability.
Kimura T; Shuto D; Hamada Y; Igawa N; Kasai S; Liu P; Hidaka K; Hamada T; Hayashi Y; Kiso Y
Bioorg Med Chem Lett; 2005 Jan; 15(1):211-5. PubMed ID: 15582441
[TBL] [Abstract][Full Text] [Related]
17. Stereochemical analysis of (hydroxyethyl)urea peptidomimetic inhibitors of gamma-secretase.
Bakshi P; Wolfe MS
J Med Chem; 2004 Dec; 47(26):6485-9. PubMed ID: 15588083
[TBL] [Abstract][Full Text] [Related]
18. Effect of helical conformation and side chain structure on γ-secretase inhibition by β-peptide foldamers: insight into substrate recognition.
Imamura Y; Umezawa N; Osawa S; Shimada N; Higo T; Yokoshima S; Fukuyama T; Iwatsubo T; Kato N; Tomita T; Higuchi T
J Med Chem; 2013 Feb; 56(4):1443-54. PubMed ID: 23342950
[TBL] [Abstract][Full Text] [Related]
19. Functional plasticity in the substrate binding site of beta-secretase.
Gorfe AA; Caflisch A
Structure; 2005 Oct; 13(10):1487-98. PubMed ID: 16216580
[TBL] [Abstract][Full Text] [Related]
20. Regulation of gamma-secretase activity in Alzheimer's disease.
Zhou S; Zhou H; Walian PJ; Jap BK
Biochemistry; 2007 Mar; 46(10):2553-63. PubMed ID: 17298085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
